What is Biote?
Biote is dedicated to revolutionizing healthcare by promoting healthy aging, recognizing that the aging process is unique to each individual. The company develops innovative educational programs and patient management options designed to help healthcare providers address the early indicators of aging on a personalized basis. This approach positions Biote at the forefront of a growing market segment focused on proactive and individualized wellness solutions.
How much funding has Biote raised?
Biote has raised a total of $175M across 1 funding round:
Debt
$175M
Debt (2021): $175M with participation from Truist Securities
Key Investors in Biote
Truist Securities
Truist Securities is a full-service corporate and investment banking firm with a rich history, dedicated to client success through comprehensive financial solutions.
What's next for Biote?
The substantial enterprise-level funding indicates Biote is poised for significant expansion and further innovation. This capital infusion will likely fuel advancements in their proprietary technologies and patient care models, enabling broader market penetration and the development of new services. The company's strategic focus on healthy aging, rather than anti-aging, aligns with a growing consumer demand for science-backed wellness and longevity solutions, suggesting a strong trajectory for future growth and market leadership.
See full Biote company page
